Genetic Variants of the HLA-A, HLA-B and AIF1 Loci Show Independent Associations with Type 1 Diabetes in Norwegian Families
Genes and Immunity (2009) 10, 141–150 & 2009 Macmillan Publishers Limited All rights reserved 1466-4879/09 $32.00 www.nature.com/gene ORIGINAL ARTICLE Genetic variants of the HLA-A, HLA-B and AIF1 loci show independent associations with type 1 diabetes in Norwegian families MC Eike1,2, M Olsson3, DE Undlien4,5, K Dahl-Jørgensen6,7, G Joner6,8, KS Rønningen9, E Thorsby1,2 and BA Lie1 1Institute of Immunology, Rikshospitalet University Hospital, Oslo, Norway; 2Institute of Immunology, Faculty Division Rikshospitalet, University of Oslo, Oslo, Norway; 3Mathematical Statistics, Chalmers University of Technology, Gothenburg, Sweden; 4Institute of Medical Genetics, Faculty Division Ulleva˚l University Hospital, University of Oslo, Oslo, Norway; 5Department of Medical Genetics, Ulleva˚l University Hospital, Oslo, Norway; 6Department of Paediatrics, Ulleva˚l University Hospital, Oslo, Norway; 7Faculty of Medicine, University of Oslo, Oslo, Norway; 8Institute of Health Management and Health Economics, University of Oslo, Oslo, Norway and 9Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway The main genetic predisposition to type 1 diabetes (T1D) is known to be conferred by the HLA-DRB1, -DQA1 and -DQB1 genes in the major histocompatibility complex (MHC). Other genetic factors within this complex are known to contribute, but their identity has often been controversial. This picture is shared with several other autoimmune diseases (AIDs). Moreover, as common genetic factors are known to exist between AIDs, associations reported with other AIDs may also be involved in T1D. In this study, we have used these observations in a candidate gene approach to look for additional MHC risk factors in T1D.
[Show full text]